News | December 06, 2007

Studer Discharge Follow Up Software Sales Hit 100 Hospitals

December 7, 2007 - Studer Group today said its Discharge Call Manager software solution (DCM) has been purchased by 100 hospitals around the country to help improve clinical outcomes and bottom-line results by ensuring staff follows up with patients after discharge and gets quantifiable answers to specific questions.

DCM is a Web-based application that automates the framework of post-discharge calls by auto-populating patient lists, showing customized questions by area and automating results for tracking.

Prior to developing DCM, Studer Group founder Quint Studer examined evidence demonstrating that, among other things, hardwiring discharge calling into the culture of a hospital or healthcare practice reduced readmissions to the hospital within 72 hours, reduced emergency department returns within 24 hours, and dramatically increased patient satisfaction with the hospital experience.

But Studer also found that most healthcare groups were inconsistent in making discharge calls, tracking the information from the calls and generating reports to share information from the calls. The software, DCM, was designed to solve these problems. McCrory oversees installation of the software at hospital sites, helps the hospitals determine which questions to ask and track, and aids the hospitals in aggregating outcomes based on the use of DCM.

DCM works by linking to a hospital's electronic medical records and auto-populating fields so hospital staff can be alerted which patients to follow up with on which day and which questions to ask that patient.

Outcomes from the Studer Group DCM follow-up interviews showed an increased efficiency of the data input process for information from discharge calls rose from zero before implementation of DCM to 71 percent after. The company also claims efficiency of patient call-list generation (targeting which patients to call and when) rose from 5 percent before DCM to 64 percent after.

For more information:

Related Content

Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
Machine Learning IDs Markers to Help Predict Alzheimer's

Neurologists use structural and diffusion magnetic resonance imaging (MRI) to identify changes in brain tissue (both gray and white matter) that are characteristic of Alzheimer's disease and other forms of dementia. The MRI images are analyzed using morphometry and tractography techniques, which detect changes in the shape and dimensions of the brain and in the tissue microstructure, respectively. In this example, the images show the normal brain of an elderly patient. Image courtesy of Jiook Cha.

News | Neuro Imaging | September 20, 2018
New research has shown a combination of two different modes of magnetic resonance imaging (MRI), computer-based...
Ingenia Ambition X 1.5T MR. This innovation is the latest advance in the Ingenia MRI portfolio, which comprises fully-digital MRI systems, healthcare informatics and a range of maintenance and life cycle services for integrated solutions that empower a faster, smarter, and simpler path to enabling a confident diagnosis
News | Magnetic Resonance Imaging (MRI) | September 14, 2018
Philips, a global leader in health technology, launched the Ingenia Ambition X 1.5T MR.
Veye Chest version 2
News | Lung Cancer | September 11, 2018
Aidence, an Amsterdam-based medical AI company, announced that Veye Chest version 2, a class IIa medical device, has
Sponsored Content | Case Study | Magnetic Resonance Imaging (MRI) | September 07, 2018 | By Sabine Sartoretti, M.D.
As soon as the Compressed SENSE technology became available to the MRI team at Kantonsspital Winterthur (Switzerland),...

Image courtesy of Philips Healthcare

Feature | Magnetic Resonance Imaging (MRI) | September 06, 2018 | By Melinda Taschetta-Millane
According to the Prescient & Strategic Intelligence report, “Global Magnetic Resonance Imaging (MRI) Market Size,...
Brain Iron Levels May Predict Multiple Sclerosis Disabilities
News | Neuro Imaging | August 31, 2018
A new, highly accurate magnetic resonance imaging (MRI) technique can monitor iron levels in the brains of multiple...
Study Finds Multiple Sclerosis Drug Slows Brain Shrinkage

An NIH-funded clinical trial suggested that the anti-inflammatory drug ibudilast may slow brain shrinkage caused by progressive MS. Image courtesy of Robert J. Fox, M.D., Cleveland Clinic.

News | Neuro Imaging | August 30, 2018
August 30, 2018 — Results from a clinical...
Rapid Cardiac MRI Technique May Cut Costs, Boost Care in Developing World
News | Magnetic Resonance Imaging (MRI) | August 29, 2018
A newly developed rapid imaging protocol quickly and cheaply diagnosed heart ailments in patients in Peru, according to...
iSchemaView RAPID Technology Now Installed in More Than 500 Stroke Centers
News | Neuro Imaging | August 27, 2018
iSchemaView announced that more than 575 stroke centers in 22 countries have selected the RAPID advanced imaging...